VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Clinical trial at Duke University

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Mar 04, 2022 10:19am

82 Views

Post# 34482948

RE:RE:Clinical trial at Duke University

G1945V wrote:

VENTRIPOINT SINGLE VENTRICLE STUDY

March 02, 2022

Conditions: Congenital Heart Disease; Single-ventricle
Interventions: Device: Transthoracic Echocardiogram or Cardiac MRI; Device: Ventripoint Echocardiogram
Sponsor: Duke University
Not yet recruiting

G1945V

Don't they say they can do a test in about 10 minutes? Isn't that one of the advantages they promote vs an MRI i.e. the time factor? This is March 4, 2022 and the estimated completion date for this trial is August of 2023 - about 17 months?

"Estimated Primary Completion Date August 1, 2023 (Final data collection date for primary outcome measure)"

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?